These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 20515470)

  • 41. TAB3 upregulates PIM1 expression by directly activating the TAK1-STAT3 complex to promote colorectal cancer growth.
    Li Q; Chen L; Luo C; ChenYan ; Ge J; Zhu Z; Wang K; Yu X; Lei J; Liu T; Peng X; Liu X; Yuan R
    Exp Cell Res; 2020 Jun; 391(1):111975. PubMed ID: 32229191
    [TBL] [Abstract][Full Text] [Related]  

  • 42. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.
    Pulukuri SM; Gondi CS; Lakka SS; Jutla A; Estes N; Gujrati M; Rao JS
    J Biol Chem; 2005 Oct; 280(43):36529-40. PubMed ID: 16127174
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SPOP regulates prostate epithelial cell proliferation and promotes ubiquitination and turnover of c-MYC oncoprotein.
    Geng C; Kaochar S; Li M; Rajapakshe K; Fiskus W; Dong J; Foley C; Dong B; Zhang L; Kwon OJ; Shah SS; Bolaki M; Xin L; Ittmann M; O'Malley BW; Coarfa C; Mitsiades N
    Oncogene; 2017 Aug; 36(33):4767-4777. PubMed ID: 28414305
    [TBL] [Abstract][Full Text] [Related]  

  • 44. SIRT3 inhibits prostate cancer by destabilizing oncoprotein c-MYC through regulation of the PI3K/Akt pathway.
    Quan Y; Wang N; Chen Q; Xu J; Cheng W; Di M; Xia W; Gao WQ
    Oncotarget; 2015 Sep; 6(28):26494-507. PubMed ID: 26317998
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phosphorylation of NFATC1 at PIM1 target sites is essential for its ability to promote prostate cancer cell migration and invasion.
    Eerola SK; Santio NM; Rinne S; Kouvonen P; Corthals GL; Scaravilli M; Scala G; Serra A; Greco D; Ruusuvuori P; Latonen L; Rainio EM; Visakorpi T; Koskinen PJ
    Cell Commun Signal; 2019 Nov; 17(1):148. PubMed ID: 31730483
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nkx3.1 and Myc crossregulate shared target genes in mouse and human prostate tumorigenesis.
    Anderson PD; McKissic SA; Logan M; Roh M; Franco OE; Wang J; Doubinskaia I; van der Meer R; Hayward SW; Eischen CM; Eltoum IE; Abdulkadir SA
    J Clin Invest; 2012 May; 122(5):1907-19. PubMed ID: 22484818
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
    Choe C; Chen N; Sawadogo M
    Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A promising natural product in diffuse large B-cell lymphoma therapy by targeting PIM1.
    Zhang X; Su Q; Zhang Y; Rong R; Chen S; He L; Zhuang W; Li B
    Ann Hematol; 2024 Aug; 103(8):2905-2915. PubMed ID: 38424303
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The PIM family of oncoproteins: small kinases with huge implications in myeloid leukemogenesis and as therapeutic targets.
    Saurabh K; Scherzer MT; Shah PP; Mims AS; Lockwood WW; Kraft AS; Beverly LJ
    Oncotarget; 2014 Sep; 5(18):8503-14. PubMed ID: 25238262
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long non-coding RNA GHET1 promotes gastric carcinoma cell proliferation by increasing c-Myc mRNA stability.
    Yang F; Xue X; Zheng L; Bi J; Zhou Y; Zhi K; Gu Y; Fang G
    FEBS J; 2014 Feb; 281(3):802-13. PubMed ID: 24397586
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
    Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
    Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ERK and AKT signaling drive MED1 overexpression in prostate cancer in association with elevated proliferation and tumorigenicity.
    Jin F; Irshad S; Yu W; Belakavadi M; Chekmareva M; Ittmann MM; Abate-Shen C; Fondell JD
    Mol Cancer Res; 2013 Jul; 11(7):736-47. PubMed ID: 23538858
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dissection of PIM serine/threonine kinases in FLT3-ITD-induced leukemogenesis reveals PIM1 as regulator of CXCL12-CXCR4-mediated homing and migration.
    Grundler R; Brault L; Gasser C; Bullock AN; Dechow T; Woetzel S; Pogacic V; Villa A; Ehret S; Berridge G; Spoo A; Dierks C; Biondi A; Knapp S; Duyster J; Schwaller J
    J Exp Med; 2009 Aug; 206(9):1957-70. PubMed ID: 19687226
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of PIM1 substrates reveals a role for NDRG1 phosphorylation in prostate cancer cellular migration and invasion.
    Ledet RJ; Ruff SE; Wang Y; Nayak S; Schneider JA; Ueberheide B; Logan SK; Garabedian MJ
    Commun Biol; 2021 Jan; 4(1):36. PubMed ID: 33398037
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PIM protein kinases regulate the level of the long noncoding RNA H19 to control stem cell gene transcription and modulate tumor growth.
    Singh N; Padi SKR; Bearss JJ; Pandey R; Okumura K; Beltran H; Song JH; Kraft AS; Olive V
    Mol Oncol; 2020 May; 14(5):974-990. PubMed ID: 32146726
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pim family kinases enhance tumor growth of prostate cancer cells.
    Chen WW; Chan DC; Donald C; Lilly MB; Kraft AS
    Mol Cancer Res; 2005 Aug; 3(8):443-51. PubMed ID: 16123140
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Highly tumorigenic human androgen receptor-positive prostate cancer cells overexpress angiogenin.
    Kawada M; Inoue H; Arakawa M; Takamoto K; Masuda T; Ikeda D
    Cancer Sci; 2007 Mar; 98(3):350-6. PubMed ID: 17270024
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Dual Inhibition of RNA Pol I Transcription and PIM Kinase as a New Therapeutic Approach to Treat Advanced Prostate Cancer.
    Rebello RJ; Kusnadi E; Cameron DP; Pearson HB; Lesmana A; Devlin JR; Drygin D; Clark AK; Porter L; Pedersen J; Sandhu S; Risbridger GP; Pearson RB; Hannan RD; Furic L
    Clin Cancer Res; 2016 Nov; 22(22):5539-5552. PubMed ID: 27486174
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pim1 supports human colorectal cancer growth during glucose deprivation by enhancing the Warburg effect.
    Zhang M; Liu T; Sun H; Weng W; Zhang Q; Liu C; Han Y; Sheng W
    Cancer Sci; 2018 May; 109(5):1468-1479. PubMed ID: 29516572
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PIM1 is a Poor Prognostic Factor for and Potential Therapeutic Target in Serous Carcinoma of the Endometrium.
    Takeuchi H; Miyamoto T; Fuseya C; Asaka R; Ida K; Ono M; Tanaka Y; Shinagawa M; Ando H; Asaka S; Shiozawa T
    Int J Gynecol Pathol; 2023 May; 42(3):282-292. PubMed ID: 35443252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.